Buccal Cortical Separation and Lateralization for Horizontal Ridge Augmentation

Horizontal Ridge Deficiency Clinical Trial

Official title:

Qualitative and Quantitative Assessment of Autogenous Versus Xenogenic Horizontal Ridge Augmentation After Mandibular Ridge-split With Buccal Cortical Lateralization: A Randomizedcontrolled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05286541
• Other study ID #: OMFS 3-3-9
• Status: Completed
• Phase: N/A
• Start date: April 1, 2022
• Est. completion date: December 30, 2023

Study information

• Verified date: April 2024
• Source: Cairo University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Cases with horizontal ridge deficiency less than what is possible for ridge splitting were recruited and the buccal cortex was totally separated and lateralized at the desired distance for augmentation

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: December 30, 2023
• Est. primary completion date: December 30, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

• suffering only from posterior mandibular horizontal ridge deficiency and with adequate inter-arch space to accommodate the future restoration

Exclusion Criteria:

• Heavy smokers, diabetics, patients with bleeding problems, liver and kidney diseases, bone diseases that can affect bone healing, previous history of any ridge augmentation procedure in the posterior mandible, and those undergoing or planned for radiotherapy or chemotherapy

Related Conditions & MeSH terms

• Horizontal Ridge Deficiency

Intervention

Procedure:
• Lateralized buccal cortex with xenograft
the buccal cortex of the deficient ridge was separated and lateralized then fixed at the desired distance
• Lateralized buccal cortex with autogenous particulate
lateralized buccal cortex with autogenous particulate

Locations

Country	Name	City	State
Egypt	Faculty of dentistry, Cairo University	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in horizontal bone gain	the net average bone gain (in millimeters) was calculated: by calculating the difference between the immediate post operative bone width measured on the Immediate CBCT and the six months bone width measured on the six months CBCT	six months after the operation
Secondary	Bone area percent	histomorphometric analysis of core biopsies was done at the time of implant insertion to determine the bone area percent at the implant sites	Six months after the operation